Thomas Kodadek

Thomas Kodadek

Auto-generated profile, based on publicly available information

Thomas Kodadek

Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, 120 Scripps Way, Jupiter, Florida 33458, United States

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Cell
Verified
Journal Article
Closed access
MRM. Muralidhar Reddy
M. Muralidhar Reddy
RWRosemary Wilson
Rosemary Wilson
JWJohnnie Wilson
Johnnie Wilson
SCSteven Connell
Steven Connell
AGAnne Gocke
Anne Gocke
TKThomas Kodadek
Thomas Kodadek

24 June 2011 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
TKThomas Kodadek
Thomas Kodadek
Combinatorial chemistry provides a powerful tool for the rapid creation of large numbers of synthetic compounds. Ideally, these libraries should be a rich source of bioactive molecules, but there is the general feeling that the initial promise of combinatorial chemistry has not yet been realized. In particular, enthusiasm for conducting unbiased (non-structure-guided) screens of large libraries for protein or RNA ligands has waned. A central challenge in this area is to devise methods for the synthesis of chemically diverse, high-quality libraries of molecules with many of the desirable features of natural products. These include diverse functionality, a significant representation of chiral sp3 centers that provide conformational bias to the molecule, significant skeletal diversity, and good pharmacokinetic properties. However, these libraries must be easy to make from cheap, readily available building blocks, ideally those that would support convenient hit optimization/structure reactivity relationship studies. Meeting these challenges will not be easy. Here I review some recent advances in this area and provide some thoughts on likely important developments in the next few years.

14 March 2010 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
JLJiyong Lee
Jiyong Lee
DUD Gomika Udugamasooriya
D Gomika Udugamasooriya
HLHyun-Suk Lim
Hyun-Suk Lim
TKThomas Kodadek
Thomas Kodadek
Ru(II)(tris-bipyridyl)2+ derivatives photocatalytically generate singlet oxygen. Attaching these ruthenium conjugates to small-molecule inhibitors of intracellular or integral membrane proteins turned modest-potency compounds into chemical knockout reagents that potently inactivated targets in response to light. Advances in high-throughput screening now enable the rapid discovery of bioactive small molecules, but these primary hits almost always exhibit modest potency. We report a strategy for the transformation of these hits into much more potent inhibitors without compound optimization. Appending a derivative of Ru(II)(tris-bipyridyl)2+, an efficient photosensitizer of singlet oxygen production, to synthetic protein-binding compounds results in highly potent and specific target protein inactivation upon irradiation with visible light.

15 April 2019 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
PDPaige Dickson
Paige Dickson
TKThomas Kodadek
Thomas Kodadek
We discuss here the chemical composition of DNA-encoded libraries likely to be made in the near future.

1 March 2013 in Chemistry & Biology
Verified
Journal Article
Closed access
YGYu Gao
Yu Gao
TKThomas Kodadek
Thomas Kodadek

1 January 2010 in Chemistry & Biology
Verified
Journal Article
Closed access
JAJohn M. Astle
John M. Astle
LSLevi S. Simpson
Levi S. Simpson
YHYong Huang
Yong Huang
MRM. Muralidhar Reddy
M. Muralidhar Reddy
RWRosemary Wilson
Rosemary Wilson
TKThomas Kodadek
Thomas Kodadek